Research

And Grants

Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.

Submit Grant Application

Home > Research and Grants

The Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.

Grant Approval Process

Grant Approval Process

The Cure Starts Now has funded $29,679,360 USD in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 196 grants at over 100 hospitals in 29 countries.






Children’s Hospital of Philadelphia – $100,000

Amount
$100,000.00 USD
Date
December 2024

Cytokine Signaling in Diffuse Midline Glioma to Enhance GD2-Directed CAR T Cell Trafficking

Grant Information

UNC Eshelman School of Pharmacy – $50,000

Amount
$50,000.00 USD
Date
December 2024

Leveraging Open Science and Collaboration to Identify Clinical Quality ALK2 Inhibitors for DIPG

Grant Information

Murdoch Children's Research Institute – $100,000 USD / $156,914 AUD

Amount
$100,000.00 USD
Date
December 2024

Harnessing Developmental Neurobiology to Reprogram the Cell of Origin of Diffuse Midline Gliomas

Grant Information

Children’s Cancer Institute – $70,400 USD / $110,467 AUD

Amount
$70,400.00 USD
Date
December 2024

A Novel Formulation to Allow the Simultaneous Targeting of MYC Expression and Copper Chelation to Treat DIPG Tumor and Overcome Multidrug Resistance

Grant Information

The Institute for Medical Research Israel-Canada – $40,000 USD / 143,580 INS

Amount
$40,000.00 USD
Date
December 2024

CXCR1/2 Signaling Pathway: A Role in the Invasive Mechanism of DIPG

Grant Information

Children's Healthcare of Atlanta – $100,000

Amount
$100,000.00 USD
Date
November 2024

Radiation Resistance in Medulloblastoma

Grant Information

University of Texas Health Science Center at San Antonio – $100,000

Amount
$100,000.00 USD
Date
November 2024

Targeting Metabolic Vulnerabilities for Treating Medulloblastoma

Grant Information

University of Texas Health Science Center at San Antonio – $50,000

Amount
$50,000.00 USD
Date
November 2024

Targeting RRNA Modification and SNORNA Function, A Novel Concept to Treat Aggressive Medulloblastoma

Grant Information

Children’s National Medical Center – $300,000

Amount
$300,000.00 USD
Date
November 2024

Multilamellar H3K27M RNA aggregates targeting diffuse midline glioma, including diffuse intrinsic pontine glioma.

Grant Information

Children's Hospital Los Angeles – $100,000

Amount
$100,000.00 USD
Date
October 2024

Targeting FOXR2 in Diffuse Midline Gliomas

Grant Information

University Hospital of Navarra - $100,000 USD, €92,637 EUR

Amount
$100,000.00 USD
Date
October 2024

Targeting Diffuse Midline Glioma vulnerabilities as a therapeutic strategy.

Grant Information

The Institute of Cancer Research – $111,445 USD / £85,976 GBP

Amount
$111,445.00 USD
Date
October 2024

Unravelling transcriptional plasticity as a non-genetic mechanism of drug resistance in DMG.

Grant Information

Children’s Cancer Institute – $100,000 USD / $150,589 AUD

Amount
$100,000.00 USD
Date
October 2024

Targeting lactate production pathways as a novel therapy against DIPG

Grant Information

Sydney Children's Hospital - Randwick – $196,577 USD / $296,025.11 AUD

Amount
$196,577.00 USD
Date
October 2024

Unlocking the potential of the blood-brain barrier in the fight against paediatric brain gliomas.

Grant Information

McGill University - $100,000

Amount
$100,000.00 USD
Date
October 2024

Understanding tumor heterogeneity and characterizing treatment responses in ACVR1-mutated diffuse midline gliomas.

Grant Information